secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tempest Therapeutics, Inc. (TPST)
CIK:        0001544227
Form:       8-K
Filed at:   2024-06-14T23:59:59+00:00
Accession:  0001193125-24-161685
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Tempest Therapeutics announces 2024 annual meeting voting results
-----------------------------------------------------------------

- Stockholders elected Stephen Brady, Michael Raab, and Ronit Simantov as Class III directors for three-year terms.
- Advisory vote on named executive officer compensation passed with 7,466,910 for, 167,307 against, 275,440 abstentions.
- Ratification of Ernst & Young as independent auditor for FY2024 approved with 14,040,756 for, 132,300 against, 21,465 abstentions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1544227/000119312524161685/0001193125-24-161685-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1544227/000119312524161685/d853541d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-161685

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer